Explore Chemotherapy-Induced Nausea and Vomiting Prophylaxis Patterns and Patient-Reported Events to Suggest Improvements in Patient Care in Oncology-Specialized Hospitals in Vietnam
Research in Clinical Pharmacy · 2023
DOI: 10.59931/rcp.23.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Clinical Pharmacy, 2023. Verfasst von Hanh T.H. Nguyen und 6 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BYNC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Chemotherapy-induced nausea and vomiting (CINV) is considered as the most distressing side effect of chemotherapy (CT).Overuse of prophylaxis leads to waste of resources, whereas underuse results in poor CINV prevention.Therefore, it is important to explore the pattern of CINV prophylaxis and CINV occurrence to improve the quality of medication use.
Methods
This prospective, observational study was conducted in two oncology-specialized hospitals in North Vietnam in 2019 to investigate the CINV prophylaxis regimens and CINV events among cancer patients receiving intravenous high-, moderate-, or lowemetic-risk CT (HEC, MEC, or LEC, respectively) after the administration of the first cycle of CT.The Multinational Association of Supportive Care in Cancer Antiemesis Tool was used to assess nausea and vomiting.
Results
The study included 294 patients (HEC: 224, MEC: 61, and LEC: 9).They were prescribed a similar pattern of prophylaxis for both acute and delayed emesis regardless of their emetic risks.Patient-specific factors, including sex, age, balance disorder, and comorbidity, but not the emetic risk of CT, were associated with the choice of prophylactic regimens.The incidence rate of CINV was 47.3% in all patients.Multivariate analysis revealed that HEC was associated with an increased risk of acute CINV compared with MEC (odds ratio, 2.34; 95% confidence interval, 1.03-5.32),whereas female sex and younger age were associated with a higher risk of delayed CINV.
Conclusion
CINV management is challenging and may involve over-and underuse of prophylaxis.A more effective approach to prophylaxis in the context of limited resources needs to be developed to improve patient outcomes.
Zitieren
APA
Nguyen, H. T., Duong, L. K., Vu, T. D., Hoang, T. T., Bach, D. V., Hoang, H. T., & Nguyen, H. T. (2023). Explore Chemotherapy-Induced Nausea and Vomiting Prophylaxis Patterns and Patient-Reported Events to Suggest Improvements in Patient Care in Oncology-Specialized Hospitals in Vietnam. Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.23.030
Vancouver
Nguyen HT, Duong LK, Vu TD, Hoang TT, Bach DV, Hoang HT, et al. Explore Chemotherapy-Induced Nausea and Vomiting Prophylaxis Patterns and Patient-Reported Events to Suggest Improvements in Patient Care in Oncology-Specialized Hospitals in Vietnam. Research in Clinical Pharmacy. 2023. doi:10.59931/rcp.23.030
BibTeX
@article{Nguyen2023,
author = {Nguyen, Hanh T.H. and Duong, Linh K. and Vu, Tien D and Hoang, Thu T.M. and Bach, Duong V and Hoang, Hao T.L and Nguyen, Huong T.L.},
title = {Explore Chemotherapy-Induced Nausea and Vomiting Prophylaxis Patterns and Patient-Reported Events to Suggest Improvements in Patient Care in Oncology-Specialized Hospitals in Vietnam},
journal = {Research in Clinical Pharmacy},
year = {2023},
doi = {10.59931/rcp.23.030}
}
EUVIMED